New Resource From The National Library Of Medicine: LiverTox
The National Library of Medicine (NLM), is pleased to announce the release of LiverTox, a new resource for health care practitioners and researchers studying liver injury associated with prescription and nonprescription drugs, herbals, and dietary supplements – http://livertox.nih.gov/
LiverTox provides a searchable database of about 700 medications available in the United States. Drug-induced liver injury is the leading cause of acute liver failure in the United States. Some drugs directly damage the liver, while others cause damage indirectly or by an allergic reaction.
- An overview of drug-induced liver injury, including diagnostic criteria, the role of liver biopsy, descriptions of different clinical patterns and standard definitions
- A detailed report of each drug, including background, case study, product package insert, chemical makeup and structure, dose recommendations and references with links
- An interactive feature which allows users to report cases of drug-induced liver injury to the LiverTox website
LiverTox developers work with outside experts in drug-induced liver disease, as well as with specialists in arthritis, cancer, diabetes, infectious diseases, and other conditions. The database will be updated regularly with information about drug-induced liver injury as well as with new drugs and concepts.
LiverTox welcomes input and comments from users: http://livertox.nih.gov/Contactus.html
LiverTox is a joint effort within the National Institutes of Health (NIH) of the Liver Disease Research Branch of the Niational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Division of Specialized Information Services (SIS) of the NLM.